SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 58 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,776 | -6.9% | 3,364 | +5.6% | 0.00% | 0.0% |
| Q2 2023 | $83,511 | +49.1% | 3,185 | +47.9% | 0.00% | +33.3% |
| Q4 2022 | $56,026 | +3.0% | 2,154 | +13.0% | 0.00% | 0.0% |
| Q3 2022 | $54,378 | +15.9% | 1,906 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $46,926 | -56.4% | 1,906 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $107,575 | -76.7% | 1,906 | -74.4% | 0.00% | -33.3% |
| Q4 2021 | $460,821 | -10.1% | 7,435 | -8.0% | 0.01% | -14.3% |
| Q3 2021 | $512,532 | +8.2% | 8,079 | +25.5% | 0.01% | 0.0% |
| Q1 2021 | $473,717 | -1.9% | 6,439 | -3.3% | 0.01% | 0.0% |
| Q4 2020 | $482,693 | +52.1% | 6,656 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $317,292 | +13.5% | 6,656 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $279,552 | +193.8% | 6,656 | +88.9% | 0.01% | +150.0% |
| Q1 2020 | $95,148 | -57.8% | 3,524 | -39.9% | 0.00% | -50.0% |
| Q4 2019 | $225,551 | – | 5,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |